Presentation Controversies and Advances 2019 Perils of Digital Health: Controversies & Advances in the Treatment of Cardiovascular Disease Presenter: John Mandrola November 15, 2019 REGISTER for free or LOG IN to view this content Policy & Practice Presentation Controversies and Advances 2019 Up Next Presentation Controversies and Advances 2019 Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial? Presenter: Raj R. Makkar November 15, 2019 More slides + Presentation Controversies and Advances 2019 Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention Presenter: Tarun Chakravarty November 15, 2019 Presentation AHA 2019 Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study Presenter: Matthew Budoff November 18, 2019 We Recommend
Presentation Controversies and Advances 2019 Should TAVR Be Standard for Bicuspid Aortic Stenosis, Or Do We Need a Randomized Clinical Trial? Presenter: Raj R. Makkar November 15, 2019
Presentation Controversies and Advances 2019 Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention Presenter: Tarun Chakravarty November 15, 2019
Presentation AHA 2019 Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study Presenter: Matthew Budoff November 18, 2019